Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.
Müller S, Kluck R, Jagodzinski C, Brügelmann M, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Oh J, Billing H, Thumfart J, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Pavičić L, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2023 Dec;38(12):3989-3999. doi: 10.1007/s00467-023-06058-x. Epub 2023 Jul 7.
Differences in kidney prognosis between congenital and infantile nephrotic syndrome.
Inoki Y, Horinouchi T, Aoyama S, Kimura Y, Ichikawa Y, Tanaka Y, Ueda C, Kitakado H, Kondo A, Sakakibara N, Kamei K, Hamada R, Fujita N, Gotoh Y, Kaku Y, Nishiyama K, Okamoto T, Toya Y, Yamamura T, Ishimori S, Nagano C, Nozu K.
Pediatr Nephrol. 2025 Aug;40(8):2539-2549. doi: 10.1007/s00467-025-06735-z. Epub 2025 Mar 17.
Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E, Borovitz Y, Levi S, Perlman S, Landau D.
Pediatr Nephrol. 2023 Apr;38(4):1067-1073. doi: 10.1007/s00467-022-05740-w. Epub 2022 Sep 26.
[Infantile polycystic kidney disease: a case report and literature review].
Luo F, Gu WZ, Chen Z, Shi LP, Ma XL, Lin HJ, Qiu YH.
Zhonghua Er Ke Za Zhi. 2013 May;51(5):377-81.
Renal Cyst (Archived).
Sigmon DF, Shikhman R, Nielson JL.
2023 Dec 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis.
Nießl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wühl E, Tönshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K.
Mol Genet Metab. 2022 Aug;136(4):268-273. doi: 10.1016/j.ymgme.2022.06.010. Epub 2022 Jul 2.
Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K, Nießl C, Haffner D, Oh J, Okorn C, Palm K, Schlingmann KP, Wygoda S, Gahl WA.
Mol Genet Metab. 2022 Aug;136(4):282-288. doi: 10.1016/j.ymgme.2022.06.009. Epub 2022 Jul 1.
Autosomal Recessive Polycystic Kidney Disease.
Subramanian S, Leslie SW, Ahmad T.
2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Impact of propofol versus desflurane anesthesia on postoperative hepatic and renal functions in infants with living-related liver transplantation: a randomized controlled trial.
Liu W, Du M, Zhang M, Dai X, Wang H, Le Y, Zhi S, Bo L, Quan J.
BMC Med. 2024 Sep 16;22(1):397. doi: 10.1186/s12916-024-03622-6.
Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years.
Brügelmann M, Müller S, Bohlen AV, Hohenfellner K, Büscher A, Kemper MJ, Fröde K, Kanzelmeyer N, Oh J, Billing H, Gellermann J, Müller D, Weber LT, Acham-Roschitz B, Arbeiter K, Tönshoff B, Hagenberg M, Žebec MS, Haffner D, Zivicnjak M.
Pediatr Nephrol. 2024 Oct;39(10):3067-3077. doi: 10.1007/s00467-024-06421-6. Epub 2024 Jun 8.
